Location History:
- Royston, GB (1999 - 2009)
- Crowthorne, GB (2011)
- Berks, GB (2014 - 2015)
Company Filing History:
4 out of 140 
4 out of 28 
1 out of 822 
Years Active: 1999-2015
Title: Elaine Joy Derbyshire: Innovating Healthcare with Human Antibodies
Introduction: Elaine Joy Derbyshire, hailing from Berks, GB, is a pioneering inventor specializing in the development of human antibodies for healthcare applications. With an impressive portfolio of 10 patents, her work focuses on antibodies that bind the P40 subunit of human IL-12, showcasing her dedication to advancements in medical science.
Latest Patents: Elaine's recent patents revolve around human antibodies that target human interleukin-12 (hIL-12). These antibodies, whether full-length or antigen-binding portions, exhibit high affinity for hIL-12 and effectively neutralize its activity both in vitro and in vivo. They serve crucial roles in detecting and inhibiting hIL-12 activity, particularly in individuals suffering from disorders where hIL-12 plays a detrimental role. Additionally, her patents encompass nucleic acids, vectors, and host cells for expressing these recombinant human antibodies, along with methods for their synthesis.
Career Highlights: Elaine has made significant contributions to the field through her tenure at respected companies such as Abbott GmbH & Co. KG and Cambridge Antibody Technology Limited. Her expertise and innovative approach have led to the development of groundbreaking solutions in the realm of antibody-based therapies.
Collaborations: Throughout her career, Elaine has collaborated with esteemed professionals in the industry, including coworkers like Jochen G Salfeld and Michael Roguska. These collaborations have enriched her work and fostered a culture of innovation within her projects.
Conclusion: Elaine Joy Derbyshire's inventive spirit and dedication to advancing healthcare through the development of human antibodies underscore her status as a trailblazing inventor. Her patents and collaborations stand as a testament to her contributions to the field, paving the way for transformative developments in medical science.